Wessel Thomas C.,Rabinowicz Adrian L.,Henney Iii Herbert R.,Runyan Jacob D.,Caggiano Anthony,Blight Andrew
申请号：
NZ71314012
公开号：
NZ713140A
申请日:
2012.01.27
申请国别(地区):
NZ
年份:
2017
代理人:
摘要：
Provided is the use of 4-aminopyridine, 3-aminopyridine or 3,4-diaminopyridine or a pharmaceutically acceptable salt thereof in the manufacture of a composition for treating a sign or symptom of cerebral palsy (”CP”) or an impairment or alteration consequent to CP in a patient with CP, and wherein the sign or symptom of CP or the impairment or alteration consequent to CP is not an impairment in mental status.
